Adverum Clinical Site 252 is a clinical research site located in Portland, Oregon, United States 97225.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
Adverum Clinical Site 252 has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD.
Sponsors: Adverum Biotechnologies, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Oregon · View every site in Portland
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Adverum Clinical Site 252 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Adverum Clinical Site 252 has 1 clinical trials on record, with 1 currently active. Their work covers Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD.
Adverum Clinical Site 252 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.